Question

A 37-year-old with newly identified metabolic dysfunction-associated steatotic liver disease (MASLD) has FIB-4 of 2.1 and BMI 34 kg/m². What risk assessment step is recommended next in primary care?

Accepted Answer

Order vibration-controlled transient elastography or refer for elastography

Answer

Reassure; no further fibrosis assessment is needed

Answer

Start statin and repeat LFTs in 1 year only

Answer

Liver biopsy immediately for all MASLD

Answer

Start ursodiol

Practice question

A 37-year-old with newly identified metabolic dysfunction-associated steatotic liver disease (MASLD) has FIB-4 of 2.1 and BMI 34 kg/m². What risk assessment step is recommended next in primary care?